EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS
ABSTRACT BACKGROUND: Non-alcoholic fatty liver disease has been progressively diagnosed in the general population as a consequence of the increased prevalence of obesity and type 2 diabetes mellitus, its main risk factors. It is characterized by accumulation of fat in the hepatocytes associated wi...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
|
| Series: | Arquivos de Gastroenterologia |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032019000300256&lng=en&tlng=en |
| _version_ | 1818442587791425536 |
|---|---|
| author | Paula Cenira Senger de CASTRO Helen Caroline Perussolo ALBERTON Maria Lucia Alves PEDROSO Daphne Benatti Gonçalves MORSOLETTO Alcindo PISSAIA JUNIOR Cláudia Alexandra Pontes IVANTES |
| author_facet | Paula Cenira Senger de CASTRO Helen Caroline Perussolo ALBERTON Maria Lucia Alves PEDROSO Daphne Benatti Gonçalves MORSOLETTO Alcindo PISSAIA JUNIOR Cláudia Alexandra Pontes IVANTES |
| author_sort | Paula Cenira Senger de CASTRO |
| collection | DOAJ |
| description | ABSTRACT BACKGROUND: Non-alcoholic fatty liver disease has been progressively diagnosed in the general population as a consequence of the increased prevalence of obesity and type 2 diabetes mellitus, its main risk factors. It is characterized by accumulation of fat in the hepatocytes associated with lobular inflammation and balonization, which can lead to cirrhosis and hepatocarcinoma. Thus, a characterization and follow-up of a progression of the fibrosis level of these patients becomes important, being that the transient hepatic elastography is a reliable method for this evaluation with a measure of the kapa index. OBJECTIVE: To evaluate the progression of hepatic fibrosis through elastography in patients with non-alcoholic fatty liver disease. METHODS: Patients who had previously performed hepatic biopsy and noninvasive scores for non-alcoholic steatohepatitis (NASH) and fibrosis were included in the study. These same subjects were then submitted to current clinical evaluation, laboratory and liver elastography tests, defining the level of liver fibrosis, about 10 years after the first evaluation. RESULTS: Data were analyzed for 66 patients previously submitted to liver biopsy. Of these, 16 were not found, four could not participate because they were debilitated due to hepatic cirrhosis, two had died from an automobile accident and five from complications of cirrhosis of the liver. Therefore, of the 50 patients with a known history, 9 (18%) had died of cirrhosis or were unable to attend the examination because of their liver disease. The remaining population was predominantly female (61.5%), mean age of 63 years, being overweight, dyslipidemia (76.9%), disorders of the glycemic profile (76.9%), and metabolic syndrome (82.1%). Of the 39 cases evaluated, 35% had the same degree of fibrosis at the initial evaluation (biopsy) and at the current evaluation (elastography), 33% had an increase in the degree of fibrosis and another 30% had a decrease in the degree of fibrosis. Twenty-eight patients had NASH at baseline. Regarding these patients, it was observed in the current evaluation, that 25% remained stable in the degree of fibrosis, 39% progressed, and 35% regressed. CONCLUSION: Despite some limitations of our study, such as the small number of patients, and the use of two different methods of evaluation (biopsy and elastography), the data obtained allow us to conclude that of the 39 evaluated cases, 33% (13) presented progression of fibrosis and the total group of 50 patients, 42% had cirrhosis or died due to liver disease. The presence of NASH on hepatic biopsy did not prove to be, in our study, a predictive of the evolution of hepatic fibrosis in the patients. |
| first_indexed | 2024-12-14T18:46:31Z |
| format | Article |
| id | doaj.art-f6af0ca2178443d792a4dbee8ec9ef27 |
| institution | Directory Open Access Journal |
| issn | 1678-4219 |
| language | English |
| last_indexed | 2024-12-14T18:46:31Z |
| publisher | Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE) |
| record_format | Article |
| series | Arquivos de Gastroenterologia |
| spelling | doaj.art-f6af0ca2178443d792a4dbee8ec9ef272022-12-21T22:51:22ZengInstituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)Arquivos de Gastroenterologia1678-421956325626010.1590/s0004-2803.201900000-48S0004-28032019000300256EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARSPaula Cenira Senger de CASTROHelen Caroline Perussolo ALBERTONMaria Lucia Alves PEDROSODaphne Benatti Gonçalves MORSOLETTOAlcindo PISSAIA JUNIORCláudia Alexandra Pontes IVANTESABSTRACT BACKGROUND: Non-alcoholic fatty liver disease has been progressively diagnosed in the general population as a consequence of the increased prevalence of obesity and type 2 diabetes mellitus, its main risk factors. It is characterized by accumulation of fat in the hepatocytes associated with lobular inflammation and balonization, which can lead to cirrhosis and hepatocarcinoma. Thus, a characterization and follow-up of a progression of the fibrosis level of these patients becomes important, being that the transient hepatic elastography is a reliable method for this evaluation with a measure of the kapa index. OBJECTIVE: To evaluate the progression of hepatic fibrosis through elastography in patients with non-alcoholic fatty liver disease. METHODS: Patients who had previously performed hepatic biopsy and noninvasive scores for non-alcoholic steatohepatitis (NASH) and fibrosis were included in the study. These same subjects were then submitted to current clinical evaluation, laboratory and liver elastography tests, defining the level of liver fibrosis, about 10 years after the first evaluation. RESULTS: Data were analyzed for 66 patients previously submitted to liver biopsy. Of these, 16 were not found, four could not participate because they were debilitated due to hepatic cirrhosis, two had died from an automobile accident and five from complications of cirrhosis of the liver. Therefore, of the 50 patients with a known history, 9 (18%) had died of cirrhosis or were unable to attend the examination because of their liver disease. The remaining population was predominantly female (61.5%), mean age of 63 years, being overweight, dyslipidemia (76.9%), disorders of the glycemic profile (76.9%), and metabolic syndrome (82.1%). Of the 39 cases evaluated, 35% had the same degree of fibrosis at the initial evaluation (biopsy) and at the current evaluation (elastography), 33% had an increase in the degree of fibrosis and another 30% had a decrease in the degree of fibrosis. Twenty-eight patients had NASH at baseline. Regarding these patients, it was observed in the current evaluation, that 25% remained stable in the degree of fibrosis, 39% progressed, and 35% regressed. CONCLUSION: Despite some limitations of our study, such as the small number of patients, and the use of two different methods of evaluation (biopsy and elastography), the data obtained allow us to conclude that of the 39 evaluated cases, 33% (13) presented progression of fibrosis and the total group of 50 patients, 42% had cirrhosis or died due to liver disease. The presence of NASH on hepatic biopsy did not prove to be, in our study, a predictive of the evolution of hepatic fibrosis in the patients.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032019000300256&lng=en&tlng=enHepatopatia gordurosa não alcoólicaTécnicas de imagem por elasticidadeCirrose hepáticaFígado gorduroso |
| spellingShingle | Paula Cenira Senger de CASTRO Helen Caroline Perussolo ALBERTON Maria Lucia Alves PEDROSO Daphne Benatti Gonçalves MORSOLETTO Alcindo PISSAIA JUNIOR Cláudia Alexandra Pontes IVANTES EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS Arquivos de Gastroenterologia Hepatopatia gordurosa não alcoólica Técnicas de imagem por elasticidade Cirrose hepática Fígado gorduroso |
| title | EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS |
| title_full | EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS |
| title_fullStr | EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS |
| title_full_unstemmed | EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS |
| title_short | EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS |
| title_sort | evaluation of progression of hepatic fibrosis in a group of patients with non alcoholic fatty liver disease accompanied for 10 years |
| topic | Hepatopatia gordurosa não alcoólica Técnicas de imagem por elasticidade Cirrose hepática Fígado gorduroso |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032019000300256&lng=en&tlng=en |
| work_keys_str_mv | AT paulacenirasengerdecastro evaluationofprogressionofhepaticfibrosisinagroupofpatientswithnonalcoholicfattyliverdiseaseaccompaniedfor10years AT helencarolineperussoloalberton evaluationofprogressionofhepaticfibrosisinagroupofpatientswithnonalcoholicfattyliverdiseaseaccompaniedfor10years AT marialuciaalvespedroso evaluationofprogressionofhepaticfibrosisinagroupofpatientswithnonalcoholicfattyliverdiseaseaccompaniedfor10years AT daphnebenattigoncalvesmorsoletto evaluationofprogressionofhepaticfibrosisinagroupofpatientswithnonalcoholicfattyliverdiseaseaccompaniedfor10years AT alcindopissaiajunior evaluationofprogressionofhepaticfibrosisinagroupofpatientswithnonalcoholicfattyliverdiseaseaccompaniedfor10years AT claudiaalexandrapontesivantes evaluationofprogressionofhepaticfibrosisinagroupofpatientswithnonalcoholicfattyliverdiseaseaccompaniedfor10years |